Kaplan-Meier survival curves also revealed that NSCLC patients with high ROR2 expression, high Wnt5a expression, and advanced TNM stage had significantly poorer prognosis (Figure 3). This evidence concerns the gene WNT5A and non-small cell lung carcinoma.